Enrichment of B Cell Receptor Signaling and Epidermal Growth Factor Receptor Pathways in Monoclonal Gammopathy of Undetermined Significance: A Genome-Wide Genetic Interaction Study

Molecular Medicine - United States
doi 10.1186/s10020-018-0031-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Monoclonal Gammopathy of Undetermined Significance

English

Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance

Clinical Cancer Research
Cancer ResearchOncology
2009English

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Haematologica
Hematology
2011English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America
OncologyHematology
2007English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Concurrent Mastocytosis and Monoclonal Gammopathy of Undetermined Significance, a Case Series

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

FOXP1 Expression in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Pathology International
MedicineForensic MedicinePathology
2009English

Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2010English

Gamma-Heavy Chain Monoclonal Gammopathy With Undetermined Significance (MGUS)

Journal of clinical and experimental hematopathology : JCEH
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy